Anti-Giantin [TA10]
(Antibody
#188878)
-
PurposeAnti-Giantin recombinant mouse monoclonal antibody
-
Depositing Lab
-
Recommended Applications
Ordering
Item | Catalog # | Description | Quantity | Price (USD) | |
---|---|---|---|---|---|
Recombinant Antibody | 188878-rAb | 100 µg of purified recombinant antibody | $250 * | ||
Recombinant Antibody trial size | 188878-rAb.T | 20 µg of purified recombinant antibody | $85 * |
* Login to view industry pricing.
Features
-
Source SpeciesM. musculus (mouse)
-
IsotypeIgG2a
-
Light Chain Typekappa
-
Amino Acid Sequences
Sequences (2) — Accept Affinity Reagent Sequence Policy
Production & Usage
-
PurificationPurification from cell culture supernatant using affinity chromatography followed by buffer exchange with centrifugal columns.
-
Storage BufferPBS + 1 mM sodium azide
Delivery
-
Concentration0.9–1.1 mg/mL
-
StorageUpon receipt, prepare single use aliquots and store at -20 °C until use. Avoid multiple freeze thaw cycles.
-
ShipmentBlue ice or room temp
Resource Information
-
Persistent Resource IdentifierRRID:AB_2928070
Terms and Licenses
-
Academic/Nonprofit Terms
-
Industry Terms
- Zeocin® is an InvivoGen trademark.
Trademarks:
Target Antigen
Protein | Golgin subfamily B member 1 |
---|---|
Antigen Description | Purified Golgi complexes from rat liver |
Species | H. sapiens (human) |
Gene | GOLGB1 |
Alternative Names |
|
External References |
|
Applications (1)
Immunocytochemistry
These antibodies were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the antibodies were described, and include Addgene in the Materials and Methods of your future publications.
-
For your Materials & Methods section:
Anti-Giantin [TA10] - from Melina Fan (Addgene antibody # 188878 ; http://n2t.net/addgene:188878 ; RRID:AB_2928070) -
For your References section:
Recombinant antibodies against subcellular fractions used to track endogenous Golgi protein dynamics in vivo. Nizak C, Martin-Lluesma S, Moutel S, Roux A, Kreis TE, Goud B, Perez F. Traffic. 2003 Nov;4(11):739-53. doi: 10.1034/j.1600-0854.2003.00132.x. 10.1034/j.1600-0854.2003.00132.x PubMed 14617357